Effect of genetic variants GSTA1 and CYP39A1 and age on busulfan clearance in pediatric patients undergoing hematopoietic stem cell transplantation

Author： ten Brink Marloes H   van Bavel Tom   Swen Jesse J   Straaten Tahar van der   Bredius Robbert GM   Lankester Arjan C   Zwaveling Juliëtte   Guchelaar Henk-Jan  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.14, 2013-11, pp. : 1683-1690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intravenous Busulfan: In the Conditioning Treatment of Pediatric Patients Prior to Hematopoietic Stem Cell Transplantation

By Hoy Sheridan M.   Lyseng-Williamson Katherine A.  

Pediatric Drugs, Vol. 9, Iss. 4, 2007-01 ,pp. : 271-278

Adis International

Access to resources Recommend Favorite

Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?

By Ansari Marc   Krajinovic Maja  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1729-1732

Future Medicine

Access to resources Recommend Favorite

Busulfan in hematopoietic stem cell transplant setting

By McCune Jeannine S   Holmberg Leona A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 957-969

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 4, 2015-07 ,pp. : 259-262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenetic Aspects of Drug Metabolizing Enzymes in Busulfan Based Conditioning Prior to Allogenic Hematopoietic Stem Cell Transplantation in Children

By  

Current Drug Metabolism, Vol. 15, Iss. 3, 2014-03 ,pp. : 251-264

Bentham Science Publishers

Access to resources Recommend Favorite